HSC has, in exercise of powers conferred on it by sections of the Misuse of Drugs (Bailiwick of Guernsey) Law, 1974 and the Misuse of Drugs (Amendment) (Bailiwick of Guernsey) Law, 2000 provided an exemption for certain products from various prohibitions in law regarding the import, export, possession and supply of CBD products of a specified description.
It must be stressed that this exemption does not extend to the commercial exportation of CBD products i.e. fulfilment, this requires HSC to grant a licence.
CBD (Cannabidiol) is one of the 150+ naturally occurring Phytocannabinoids found in certain strains of hemp and in all cannabis plant strains.
CBD products now exempt are those meeting the following conditions:
- Have its ingredients clearly labelled
- Contain an aggregate of not more than 3% cannabinol or cannabinol derivatives relative to its CBD content, by weight
- Not contain any other controlled drug
- Not contain any plant material visible to the naked eye
The requirement regarding the percentage of cannabinol (or derivative) must be confirmed by either the States Analyst or by a laboratory accredited to ISO/IEC 17025 standard for forensic analysis of cannabinol (or derivatives).
This modification order, and the checks on importation carried out by the Guernsey Boarder Agency, ensures that the public can have confidence that CBD Oil products purchased in Guernsey meet the requirements of the Misuse of Drugs Law.